
<!-- saved from url=(0064)file:///C:/Users/ygowda/Desktop/output/18646816/18646816_13.html -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"></head><body><table border="1">
<tbody><tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Particulars</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Q4'FY17</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Q3'FY18 | Q4'FY18</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">YoY Growth</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">QoQ Growth</span></p></td></tr>
<tr><td>
<p></p></td><td colspan="3" style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">(Rs Crs)</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font6">(%)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Total Revenue from Operations (Net of Excise)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">1,598</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">2,068</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">2,252</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">41%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">9%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Pharmaceuticals</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">804</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,101</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,238</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">54%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">12%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Life Science Ingredients</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">743</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">922</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">968</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">30%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">5%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Drug Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">51</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">45</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">47</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">-8%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">5%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Total Expenditure</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,293</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,651</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,794</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">39%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">9%</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font6">Other Income</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">11</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">3</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">23</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">118%</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">611%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">EBITDA from Operations</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Pharmaceuticals</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">216</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">245</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">298</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">38%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">22%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Life Science Ingredients</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">116</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">206</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">187</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">62%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">-9%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Drug Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">6</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">3</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">85%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">230%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Corporate (Expenses)/lncome</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(22)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(23)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(15)</span></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">316</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">431</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">481</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">52%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font5" style="font-weight:bold;">12</span><span class="font6" style="font-weight:bold;">%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">One time expenses</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">0</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-variant:small-caps;">(id</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">0</span></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Reported EBITDA</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">316</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">420</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">481</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">52%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">14%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Depreciation and Amortization</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">75</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">82</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">182</span></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Normal</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">75</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">82</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">91</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">21%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">11%</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font6">One-time</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">0</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">0</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">91</span></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font6">Finance Cost</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">80</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">77</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">72</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">-10%</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">-6%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Profit before Tax</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">160</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">261</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">227</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">42%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">-13%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Tax Expenses (Net)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">11</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">48</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">74</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">570%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">53%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Minority Interest</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(i)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">0</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(2)</span></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Net Profit After Tax and Minority Interest</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">150</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">213</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">155</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">-27%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Normalised Profit after Tax</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">150</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">223</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">226</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">51%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font5" style="font-weight:bold;">1</span><span class="font6" style="font-weight:bold;">%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Earnings Per Share - Face Value Re. 1 (Rs.)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">9.63</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">13.64</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">9.94</span></p></td><td rowspan="2">
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">Normalised Earnings Per Share</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">9.63</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">14.33</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">14.53</span></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td colspan="3" style="vertical-align:bottom;">
<p><span class="font6">(%i</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">(b</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6" style="font-weight:bold;">ps)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">EBITDA Margins from Operations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">19.7%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">20.8%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">21.3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">161</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">52</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Pharmaceuticals</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">26.9%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">22.2%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">24.1%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(278)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">189</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Life Science Ingredients</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">15.6%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">22.3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">19.3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">378</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(299)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Drug Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">10.9%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">7.0%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">22.0%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,112</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">1,504</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font6">Net Margins</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">9.4%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">10.3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">6.9%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(252)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font6">(340)</span></p></td></tr>
</tbody></table></body></html>